Cargando…

The Actual Status of Hospitals as COVID-19 Vaccination Clinics in China and Safety Monitoring of Inactivated Vaccine: A Cross-Sectional Study

BACKGROUND: The outbreak has had a devastating impact, and efforts are underway to speed up vaccination. The study’s objective was to describe the clinical characteristics of the coronavirus disease 2019 (COVID-19) vaccination clinic in the Second People’s Hospital of Fujian Province, China. Meanwhi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Jin, Zhang, Mei-quan, Huang, Mei-zheng, Lin, Gao-min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588414/ https://www.ncbi.nlm.nih.gov/pubmed/36017705 http://dx.doi.org/10.1017/dmp.2022.217

Ejemplares similares

Safety monitoring in inactivated COVID-19 vaccines by clinical pharmacists from a single center in China
por: Hu, Min, et al.
Publicado: (2022)

Safety and immunogenicity of inactivated COVID-19 vaccine in patients with metabolic syndrome: A cross-sectional observational study
por: Guo, Qiao, et al.
Publicado: (2022)

Safety, immunogenicity, and immune persistence of two inactivated COVID-19 vaccines replacement vaccination in China: An observational cohort study
por: Wang, Xiaoqi, et al.
Publicado: (2022)

Safety of inactivated COVID-19 vaccines in autoimmune encephalitis: A real-world cross-sectional survey
por: Liu, Xu, et al.
Publicado: (2023)

Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China
por: Mo, Zhaojun, et al.
Publicado: (2017)

Safety and efficacy of inactivated COVID-19 vaccines in women vaccinated during the first trimester of pregnancy
por: Ma, Yan, et al.
Publicado: (2023)

Actual status of therapeutic vaccination in non-small cell lung cancer
por: Szyszka-Barth, Katarzyna, et al.
Publicado: (2014)

Safety and Immunogenicity of Inactivated COVID-19 Vaccines Among People Living with HIV in China
por: Han, Xiaoxu, et al.
Publicado: (2022)

Safety and Immunogenicity of the Inactivated COVID-19 Vaccine Booster in People Living with HIV in China
por: Yi, Yunyun, et al.
Publicado: (2023)

JYNNEOS vaccine safety monitoring in the Republic of Korea, 2022: a cross-sectional study
por: Lee, Jaeeun, et al.
Publicado: (2023)

A Review of Inactivated COVID-19 Vaccine Development in China: Focusing on Safety and Efficacy in Special Populations
por: Hu, Lidan, et al.
Publicado: (2023)

Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies
por: Liu, Xiaoqiang, et al.
Publicado: (2022)

Willingness of Older Adults with Chronic Diseases to Receive a Booster Dose of Inactivated Coronavirus Disease 2019 Vaccine: A Cross-Sectional Study in Taizhou, China
por: Lin, Xiao-Qing, et al.
Publicado: (2022)

Comparison of Safety of Different Vaccine Boosters Following Two-Dose Inactivated Vaccines: A Parallel Controlled Prospective Study
por: Lin, Zhi-Qiang, et al.
Publicado: (2022)

Safety and Current Status of the COVID-19 Vaccine among Patients with Breast cancer: A Cross-Sectional Study from China
por: Zhang, Shaohua, et al.
Publicado: (2023)

2743. Safety of Recombinant Influenza Vaccine Compared with Inactivated Influenza Vaccine in Adults
por: Hansen, John, et al.
Publicado: (2019)

Immunogenicity and safety of an inactivated enterovirus 71 vaccine coadministered with trivalent split-virion inactivated influenza vaccine: A phase 4, multicenter, randomized, controlled trial in China
por: Chen, Yaping, et al.
Publicado: (2022)

Vaccine confidence in China after the Changsheng vaccine incident: a cross-sectional study
por: Liu, Baohua, et al.
Publicado: (2019)

Attitudes towards and safety of the SARS-CoV-2 inactivated vaccines in 188 patients with systemic lupus erythematosus: a post-vaccination cross-sectional survey
por: Tang, Qi, et al.
Publicado: (2022)

Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults
por: Murdoch, Louise, et al.
Publicado: (2023)

COVID-19 vaccine coverage, safety, and perceptions among patients with diabetes mellitus in China: a cross-sectional study
por: Li, Haolong, et al.
Publicado: (2023)

Evaluation of antibody kinetics and durability in healthy individuals vaccinated with inactivated COVID-19 vaccine (CoronaVac): A cross-sectional and cohort study in Zhejiang, China
por: Zhang, Hangjie, et al.
Publicado: (2023)

The safety of influenza vaccine in clinically cured leprosy patients in China
por: Zheng, Yi, et al.
Publicado: (2017)

Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: A cross-sectional survey
por: Hong, Jing, et al.
Publicado: (2021)

Human papillomavirus vaccination related knowledge, and recommendations among healthcare providers in Southern China: a cross-sectional survey
por: Chen, Siqi, et al.
Publicado: (2022)

Safety of Recombinant Influenza Vaccine Compared to Inactivated Influenza Vaccine in Adults: An Observational Study
por: Hansen, John, et al.
Publicado: (2020)

Safety and Immunogenicity of Sabin Strain Inactivated Poliovirus Vaccine Compared With Salk Strain Inactivated Poliovirus Vaccine, in Different Sequential Schedules With Bivalent Oral Poliovirus Vaccine: Randomized Controlled Noninferiority Clinical Trials in China
por: Hu, Yuemei, et al.
Publicado: (2019)

Web-Based Reporting of Post-Vaccination Symptoms for Inactivated COVID-19 Vaccines in Jordan: A Cross-Sectional Study
por: Nassar, Razan I., et al.
Publicado: (2022)

COVID-19 Vaccination in People Living with HIV (PLWH) in China: A Cross Sectional Study of Vaccine Hesitancy, Safety, and Immunogenicity
por: Liu, Ying, et al.
Publicado: (2021)

Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: A national cross-sectional study
por: Wang, Chao, et al.
Publicado: (2021)

Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China
por: Tung, Tao-Hsin, et al.
Publicado: (2022)

Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in China: A multicentre, non-inferiority, open-label, randomised, controlled, phase 4 trial
por: Chen, Haiping, et al.
Publicado: (2022)

Effects of maternal antibodies in infants on the immunogenicity and safety of inactivated polio vaccine in infants
por: Gao, Shuyu, et al.
Publicado: (2022)

Cost-Effectiveness of COVID-19 Sequential Vaccination Strategies in Inactivated Vaccinated Individuals in China
por: Fu, Yaqun, et al.
Publicado: (2022)

Safety and immunogenicity of the first Kazakh inactivated vaccine for COVID-19
por: Nurpeisova, Ainur, et al.
Publicado: (2022)

The safety and immunogenicity to inactivated COVID-19 vaccine in patients with hyperlipemia
por: Yang, Lei, et al.
Publicado: (2023)

Safety profile of inactivated COVID-19 vaccine in indonesian adults
por: Satari, Hindra Irawan, et al.
Publicado: (2023)

Status of continuous glucose monitoring use and management in tertiary hospitals of China: a cross-sectional study
por: Chen, Liping, et al.
Publicado: (2023)

An Improved Inactivated Influenza Vaccine with Enhanced Cross Protection
por: Ni, Yawei, et al.
Publicado: (2018)

A glimpse into the psychological status of E.N.T inpatients in China: A cross-sectional survey of three hospitals in different regions
por: Tian, Jun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_39i0opi5sb397fc0oi3a20tnp4